Terveystalo Oyj Past Earnings Performance

Past criteria checks 0/6

Terveystalo Oyj's earnings have been declining at an average annual rate of -36.1%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 7.1% per year.

Key information

-36.1%

Earnings growth rate

-36.0%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate7.1%
Return on equity-2.2%
Net Margin-0.9%
Next Earnings Update14 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Terveystalo Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

LSE:0RV1 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,329-11120
30 Jun 241,313-23110
31 Mar 241,296-3090
31 Dec 231,286-4290
30 Sep 231,27930100
30 Jun 231,2757120
31 Mar 231,27110110
31 Dec 221,2592490
30 Sep 221,25243120
30 Jun 221,24977140
31 Mar 221,20682110
31 Dec 211,1558170
30 Sep 211,10777110
30 Jun 211,0747940
31 Mar 211,0086140
31 Dec 209864650
30 Sep 209774080
30 Jun 209713480
31 Mar 201,0204680
31 Dec 191,0315470
30 Sep 1995848190
30 Jun 1988554260
31 Mar 1981559340
31 Dec 1874569410
30 Sep 1873765450
30 Jun 1873242450
31 Mar 1872729530
31 Dec 176907420
30 Sep 176469380
30 Jun 1761016350
31 Mar 1756716220
31 Dec 1654713300
31 Dec 155061310
31 Dec 14474-83300

Quality Earnings: 0RV1 is currently unprofitable.

Growing Profit Margin: 0RV1 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0RV1 is unprofitable, and losses have increased over the past 5 years at a rate of 36.1% per year.

Accelerating Growth: Unable to compare 0RV1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0RV1 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (15.5%).


Return on Equity

High ROE: 0RV1 has a negative Return on Equity (-2.15%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 06:23
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Terveystalo Oyj is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Iiris ThemanCarnegie Investment Bank AB
Panu LaitinmäkiDanske Bank
Sami SarkamiesDanske Bank